Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data

dc.date.accessioned	2020-10-21T06:44:36Z
dc.date.available	2020-10-21T06:44:36Z
dc.date.issued	2020
dc.date.issued	2020/09/08
dc.identifier.citation	Kalyoncu U, Kiraz S, Bes C.Clin Exp Rheumatol. 2020 Sep 4. Online ahead of print.
dc.identifier.uri	http://doi.org/
dc.identifier.uri	https://hdl.handle.net/20.500.12619/71170
dc.description	PMID = 32896266
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data
dc.type	article
dc.relation.journal	Clin Exp Rheumatol
dc.contributor.author	Kimyon G
dc.contributor.author	Kalyoncu U
dc.contributor.author	Kiraz S
dc.contributor.author	Bes C
dc.contributor.author	Coşkun N
dc.contributor.author	Yağiz B
dc.contributor.author	Küçükşahin O
dc.contributor.author	Kanitez N
dc.contributor.author	Erden A
dc.contributor.author	Kiliç L
dc.contributor.author	Bilgin E
dc.contributor.author	Kaşifoğlu T
dc.contributor.author	Emmungil H
dc.contributor.author	Koca SS
dc.contributor.author	Akar S
dc.contributor.author	Çinar M
dc.contributor.author	Yazisiz V
dc.contributor.author	Ateş A
dc.contributor.author	Ersözlü D
dc.contributor.author	Gönüllü E
dc.contributor.author	Mercan R
dc.contributor.author	Ertenli İ.
dc.relation.publicationcategory	Makale - Uluslararası Hakemli Dergi